Old Republic International Corp Gilead Sciences, Inc. Transaction History

Old Republic International Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $32.5 Million - $41.6 Million	-518,500 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$61.62 - $67.78 $13.4 Million - $14.8 Million	218,000 Added 72.55%	518,500 $33.7 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $4.95 Million - $5.55 Million	80,000 Added 36.28%	300,500 $20.3 Million
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $4.47 Million - $5.01 Million	-71,500 Reduced 24.49%	220,500 $14.3 Million
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $3.94 Million - $5.14 Million	65,000 Added 28.63%	292,000 $18.3 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $14.7 Million - $17.2 Million	227,000 New	227,000 $16.1 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Old Republic International Corp, based on Form 13F filings with the SEC.

Stay updated on Old Republic International Corp with notifications on news.